Fear not

Advertise with Islandsun

Blood clot is not related to AstraZeneca vaccine: WHO


Blood clots is no side effect of the AstraZeneca vaccine, assures World Health Organisation (WHO), Solomon Islands.

Simon Burggraaf of World Health Organisation (WHO) Solomon Islands elaborates, saying data from Europe and Asia-India all show the blood clot incidents to be coincidental with vaccine administration.

WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19 vaccine in its latest statement, says:

“Based on a careful scientific review of the available information, the subcommittee came to the following conclusions and recommendations: 

“The AstraZeneca COVID-19 vaccine (including Covishield) continues to have a positive benefit-risk profile, with tremendous potential to prevent infections and reduce deaths across the world.

“The available data do not suggest any overall increase in clotting conditions such as deep venous thrombosis or pulmonary embolism following administration of COVID-19 vaccines. Reported rates of thromboembolic events after COVID-19 vaccines are in line with the expected number of diagnoses of these conditions. Both conditions occur naturally and are not uncommon. They also occur as a result of COVID-19.  The observed rates have been fewer than expected for such events.

“While very rare and unique thromboembolic events in combination with thrombocytopenia, have also been reported following vaccination with the AstraZeneca COVID-19 vaccine in Europe, a causal relationship between these rare events has not been established at this time.”